Use of hypoglycemic agent for treating impaired glucose metabolism

Details for Australian Patent Application No. 2005200398 (hide)

Owner Novartis AG

Inventors Emmons, Rebecca; Muller, Beate; Guitard, Christiane

Agent Davies Collison Cave

Pub. Number AU-A-2005200398

Parent 777776

Filing date 21 January 2005

Wipo publication date 24 February 2005

Acceptance publication date 3 May 2007

International Classifications

A61K 031/198

A61P 005/50 Drugs for disorders of the endocrine system

Event Publications

17 February 2005 Complete Application Filed

24 February 2005 Application Open to Public Inspection

  Published as AU-A-2005200398

3 May 2007 Application Accepted

  Published as AU-A-2005200398

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200399-Intrinsically-safe battery power supply for underground mining

2005200397-Improved pasture, forage and seed production technology through pod and leaf retention on annuals of the medicago genus (annual medics)